Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- Senate
- Sponsors
- 4
- Latest action
- Feb 26, 2025
What it does
The bill amends the Public Health Service Act to reauthorize and expand a sickle cell disease prevention and treatment demonstration program, increasing annual funding from $4,455,000 to $8,205,000 for fiscal years 2025 through 2029. It shifts the program’s focus to include the prevention and treatment of complications of sickle cell disease, in addition to treatment of the disease itself, and changes the funding mechanism from contracts to grants, contracts, or cooperative agreements. The bill also expresses the sense of Congress that further research is needed to understand and find cures for heritable blood disorders, including sickle cell disease. It affects public health programs and…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
While a bill can still move, the questions are about people and money.